Ken Griffin Standard Biotools Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Standard Biotools Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 12,800 shares of LAB stock, worth $25,727. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,800

Previous 51,122 74.96%

Holding current value

$25,727

Previous $138,000 84.06%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.65 - $2.92 $1.49 Million - $2.64 Million	905,346 New	905,346 $1.6 Million
Q4 2023 Feb 14, 2024	SELL	$1.59 - $2.73 $67,107 - $115,222	-42,206 Reduced 37.18%	71,319 $157,000
Q3 2023 Nov 14, 2023	BUY	$1.9 - $3.05 $63,640 - $102,159	33,495 Added 41.85%	113,525 $329,000
Q2 2023 Aug 14, 2023	SELL	$1.47 - $2.56 $49,227 - $85,729	-33,488 Reduced 29.5%	80,030 $154,000
Q1 2023 May 15, 2023	BUY	$1.3 - $2.24 $118,965 - $204,986	91,512 Added 415.85%	113,518 $221,000
Q4 2022 Feb 14, 2023	BUY	$0.93 - $1.52 $9,274 - $15,158	9,973 Added 82.88%	22,006 $25,000
Q3 2022 Nov 14, 2022	SELL	$1.1 - $2.06 $276,372 - $517,570	-251,248 Reduced 95.43%	12,033 $13,000
Q2 2022 Aug 15, 2022	BUY	$1.6 - $3.99 $333,262 - $831,073	208,289 Added 378.76%	263,281 $421,000
Q1 2022 May 16, 2022	SELL	$2.8 - $3.96 $139,034 - $196,633	-49,655 Reduced 47.45%	54,992 $197,000
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.13 $154,253 - $260,488	42,494 Added 68.37%	104,647 $410,000
Q3 2021 Nov 15, 2021	SELL	$5.5 - $7.41 $189,084 - $254,748	-34,379 Reduced 35.61%	62,153 $410,000
Q2 2021 Aug 16, 2021	SELL	$4.35 - $6.35 $87,004 - $127,006	-20,001 Reduced 17.16%	96,532 $594,000
Q1 2021 May 17, 2021	BUY	$3.94 - $7.09 $221,278 - $398,188	56,162 Added 93.03%	116,533 $527,000
Q4 2020 Feb 16, 2021	SELL	$5.45 - $8.65 $940,315 - $1.49 Million	-172,535 Reduced 74.08%	60,371 $362,000
Q3 2020 Nov 16, 2020	BUY	$4.34 - $11.43 $815,238 - $2.15 Million	187,843 Added 416.85%	232,906 $1.73 Million
Q1 2020 May 15, 2020	BUY	$1.24 - $4.35 $55,878 - $196,024	45,063 New	45,063 $114,000
Q4 2019 Feb 14, 2020	SELL	$2.3 - $5.12 $1.13 Million - $2.51 Million	-491,015 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.63 - $12.15 $2.21 Million - $5.81 Million	-478,225 Reduced 49.34%	491,015 $2.27 Million
Q2 2019 Aug 14, 2019	BUY	$11.49 - $14.17 $610,406 - $752,781	53,125 Added 5.8%	969,240 $11.9 Million
Q1 2019 May 15, 2019	BUY	$8.47 - $14.36 $7.33 Million - $12.4 Million	865,653 Added 1715.46%	916,115 $0
Q4 2018 Feb 14, 2019	BUY	$7.18 - $8.83 $127,236 - $156,476	17,721 Added 54.12%	50,462 $434,000
Q3 2018 Nov 13, 2018	BUY	$5.92 - $8.35 $96,827 - $136,572	16,356 Added 99.82%	32,741 $0
Q2 2018 Aug 10, 2018	BUY	$4.86 - $6.24 $20,125 - $25,839	4,141 Added 33.82%	16,385 $0
Q4 2017 Feb 09, 2018	BUY	$4.46 - $6.45 $54,608 - $78,973	12,244	12,244 $72,000

Others Institutions Holding LAB

# of Institutions

148

Shares Held

269M

Call Options Held

422K

Put Options Held

40.7K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $158M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account